No abstract available
MeSH terms
-
Acute Disease
-
Cerebral Hemorrhage / complications
-
Clinical Trials, Phase III as Topic
-
Fibrinolytic Agents / therapeutic use*
-
Guidelines as Topic
-
Humans
-
Randomized Controlled Trials as Topic
-
Stroke / drug therapy*
-
Stroke / etiology
-
Thrombolytic Therapy / standards*
-
Thrombolytic Therapy / statistics & numerical data
-
Time Factors
-
Tissue Plasminogen Activator / therapeutic use*
Substances
-
Fibrinolytic Agents
-
Tissue Plasminogen Activator